Not Yet RecruitingNot Applicable

Role of Autologous Platelet Rich Plasma(PRP) Injection and Platelet Rich Fibrin Glue(PRFG) Interposition for Treatment of Anal Fistula

60 participantsStarted 2024-09

Plain-language summary

To evaluate the autologous platelet rich plasma and platelet rich fibrin glue effect on the treatment of anal fistula To asses role of platelet rich plasma and platelet rich fibrin glue in decreasing recurrence of perianal fistula

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 60 patients with perianal fistula were in the age group between 20 to 60 years old Exclusion Criteria: * Thrombocytopenia * Patient with rectovaginal fistula * fistula with chronic cavities * Acute sepsis and patient were not willing undergo this type of treatment

What they're measuring

evaluate effect of autologous platelet rich plasma and platelet rich fibrin glue in decreasing recurrence rate of anal fistula

Timeframe: 3 year

Trial details

NCT IDNCT06092398

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-09

Contact for this trial

marwa hassan thabet, master

01004748373 meromoro1010@gmail.com

View on ClinicalTrials.gov More Anal Fistula trials